C12Y 304/14001
Dipeptidyl-peptidase i , i.e. cathepsin-c
Official title: Dipeptidyl-peptidase I (3.4.14.1), i.e. cathepsin-C
C12Y304/14001 (Dipeptidyl-peptidase i , i.e. cathepsin-c) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 7
- Assignees
- 6
- Inventors
- 28
- Latest grant
- 2 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Substituted imidazoles for preventing and/or treating cell or tissue necrosis2 Apr 2024US 11,945,787 B2Ela Pharma Ltd.
- Substituted thiazoles for preventing and/or treating cell or tissue necrosis6 Apr 2021US 10,968,185 B2Ela Pharma Ltd.
- Pharmaceutical composition for treating lysosomal storage disease22 Sep 2015US 9,138,465 B2Osaka University
- Dipeptidyl peptidase-I inhibitors and uses thereof11 Feb 1997US 5,602,102 ABoard of Regents, The Univ. of TX System
- Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto11 Sep 2025US 2025/0282740 A1Ela Pharma Ltd.
- Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto5 Sep 2024US 2024/0294480 A1Ela Pharma Ltd.
- Compounds comprising a fibroblast activation protein ligand and use thereof6 Jul 2023US 2023/0212549 A13B Pharmaceuticals GmbH
- Compositions and methods for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto7 Oct 2021US 2021/0309620 A1Ela Pharma Ltd.
- Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto1 Nov 2018US 2018/0312477 A1Ela Pharma Ltd.
Most cited
By later US patents